RESHAPE
Lyon, 69373, France
NCT Number: NCT05124145
As few data are available on the epidemiology of the COVID-19 in primary care, the project aims to implement a practice-based surveillance network based on multiprofessional health homes in the French region Auvergne-Rhône-Alpes (Aura), able to monitor the evolution of the current epidemic.
Looking for future studies?
Notify MeAll sexes
Observational
Lyon, 69373, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The surveillance network will collect data on all consecutive COVID-19 cases
Time frame: 30 days after the COVID-19 suspected
Confirmed cases will be defined by the positivity of the detection of SARS-CoV-2 in RT-PCR and possibly by serology (for patients in whom a test is performed).
The incidence rate of confirmed cases will be estimated from the number of new cases confirmed by a positive biological test reported in the patient population of the participating facilities.
Research on Healthcare Performance Lab U1290
Other
Primary Care in AURA for Covid-19: Implementation of a Regional Practice-based Surveillance Network
Acronym: SOPRAC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05096260
COVID-19, COVID-19 Pandemic
Ann Arbor, Michigan, United States
View Trial DetailsNCT05188651
COVID-19, COVID-19 Pandemic
Roma, RM, Italy
View Trial DetailsNCT07436572
COVID-19, COVID-19 Pandemic
Gaziantep, Turkey (Türkiye)
View Trial DetailsNCT06036134
Behavior, COVID-19
Phoenix, Arizona, United States
View Trial Details